Found: 13
Select item for more details and to access through your institution.
Purification and further characterization of a glycoprotein from the skin mucus of Japanese eels.
- Published in:
- Journal of Fish Biology, 2004, v. 64, n. 1, p. 100, doi. 10.1111/j.1095-8649.2004.00286.x
- By:
- Publication type:
- Article
Subgroup analysis of elderly patients (pts) with diffuse large B‐cell lymphoma (DLBCL) in the Phase 3 POLARIX study.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 416, doi. 10.1002/hon.3164_306
- By:
- Publication type:
- Article
FIRST‐IN‐HUMAN STUDY OF THE EZH1 AND EZH2 DUAL INHIBITOR VALEMETOSTAT TOSYLATE (DS‐3201B) IN PATIENTS WITH RELAPSED OR REFRACTORY NON‐HODGKIN LYMPHOMAS.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.14_2879
- By:
- Publication type:
- Article
CLINICAL OUTCOMES AND DIAGNOSIS‐TO‐TREATMENT INTERVAL IN PATIENTS WITH NK/T‐CELL LYMPHOMA: 7‐YEAR FOLLOW‐UP OF THE NKEA STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 274, doi. 10.1002/hon.86_2630
- By:
- Publication type:
- Article
THE ROLE OF SURVEILLANCE COMPUTED TOMOGRAPHY IN PATIENTS WITH FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 395, doi. 10.1002/hon.65_2631
- By:
- Publication type:
- Article
ANALYSIS OF PUBLISHED TREATMENT OPTIONS FOR RELAPSED OR REFRACTORY (R/R) PERIPHERAL T–CELL LYMPHOMA (PTCL): AN EVIDENCE BASED DECISION MAKING APPROACH.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 474, doi. 10.1002/hon.153_2631
- By:
- Publication type:
- Article
CLINICAL OUTCOMES AND DIAGNOSIS‐TO‐TREATMENT INTERVAL IN PATIENTS WITH NK/T‐CELL LYMPHOMA: 7‐YEAR FOLLOW‐UP OF THE NKEA STUDY.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 274, doi. 10.1002/hon.86_2630
- By:
- Publication type:
- Article
THE ROLE OF SURVEILLANCE COMPUTED TOMOGRAPHY IN PATIENTS WITH FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 395, doi. 10.1002/hon.65_2631
- By:
- Publication type:
- Article
ANALYSIS OF PUBLISHED TREATMENT OPTIONS FOR RELAPSED OR REFRACTORY (R/R) PERIPHERAL T–CELL LYMPHOMA (PTCL): AN EVIDENCE BASED DECISION MAKING APPROACH.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 474, doi. 10.1002/hon.153_2631
- By:
- Publication type:
- Article
Fertility and social reintegration after modified CODOX- M/IVAC with or without rituximab: A questionnaire survey of non- Hodgkin lymphoma.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 355, doi. 10.1002/hon.2439_109
- By:
- Publication type:
- Article
ASSESSMENT INDEX OF CLINICAL TRANSFORMATION FROM FOLLICULAR LYMPHOMA (FL) TO DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 367, doi. 10.1002/hon.2439_123
- By:
- Publication type:
- Article
LONG-TERM FOLLOW-UP AFTER LOCALIZED RADIOTHERAPY IN PATIENTS WITH TRANSFORMED B-CELL LYMPHOMA TREATED WITH RITUXIMAB-CONTAINING CHEMOTHERAPY.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 182, doi. 10.1002/hon.2438_43
- By:
- Publication type:
- Article
Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens.
- Published in:
- Transplant Infectious Disease, 2008, v. 10, n. 4, p. 252, doi. 10.1111/j.1399-3062.2007.00291.x
- By:
- Publication type:
- Article